The overall purpose of this research study is to investigate the safety of pharmacological
therapies that may potentially improve pediatric outcomes after traumatic brain injury.
Traumatic brain injuries are the leading cause of death and disability among children and
Hypothesis: Combinational therapy with a membrane transporter and antioxidant are safe after
TBI and can overcome barriers to the brain and synergistically improve bioavailability and
efficacy the antioxidant content of the body and CNS after TBI.